| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |